Search Results for: osiris

Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells

Vatican-stem-cell-meeting

Over the years, the Vatican has expressed interest and even invested money in the adult stem cell field. Not surprisingly, they’ve also been critical of embryonic stem cell research. Interestingly their own stem cell meetings have at times stimulated heated debate for various reasons and one was even cancelled with at least part of the reason related to …

Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells Read More »

Stem cell treatment cost 2.0: legit therapy

stem-money

We hear so much about exciting potential stem cell therapies, but what about stem cell treatment cost? Some of these “therapies” are rigorously evaluated ones in the FDA clinical trial pipeline and others are available right now mainly through predatory stem cell clinics. Earlier this year I posted about the cost of the offerings of …

Stem cell treatment cost 2.0: legit therapy Read More »

Tale of 7 stem cell biotech stock woes

Ocata

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those …

Tale of 7 stem cell biotech stock woes Read More »

Stem Cell & Cell Med Industry Briefs

Where do things stand with some players in the for-profit world of stem cell and cellular medicine companies? Here are a few brief news items with quick analysis. Mesoblast is dominating the news of late. Mesoblast reported good news from its Phase II safety trial for its mesenchymal progenitor cell (MPC) product in patients with …

Stem Cell & Cell Med Industry Briefs Read More »

MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit

ABC News just reported that the FDA is allgedly “cracking down” on the publicly traded company, MiMedx (MDXG), which sells a placental derivative touted for healing powers. The Wall Street Journal is also following the story. According to ABC News: MiMedx is a publically traded, for-profit company that takes donated human placentas — solicited via a website featuring …

MiMedx (MDXG) placental “stem cell magnet” drugs attract FDA attention and lawsuit Read More »

Interview with BioTime CEO Michael West Part 1: a little stem cell history

Michael-West-PhD-CEO-of-BioTime-1-934x10241

It was my pleasure recently to  talk at length with Dr. Michael West, CEO of the Stem Cell Biotech, BioTime (BTX). West has been at the helm of BioTime since 2007 and is a true pioneer in the stem cell field. He founded Geron (GERN) and was a top leader at Advanced Cell Technology (ACT; stock …

Interview with BioTime CEO Michael West Part 1: a little stem cell history Read More »

FDA crackdown on dubious stem cell clinics actually helps companies offering legitimate therapies

A while back, I did a post on the FDA audit report of Celltex and I think I made a mistake in the title of that post: Surprising FDA audit report of Celltex a blow to for-profit adult stem cell industry. What I meant was the dubious stem cell industry. The title I used was too vague …

FDA crackdown on dubious stem cell clinics actually helps companies offering legitimate therapies Read More »

TGIF: stem cell headlines according to Google & my take on them

The metaformin story is very interesting, but why show picture of Bartolo Colon who got dubious stem cell treatment for arm injury? Some stem cell scientists express concerns about Osiris; see article by Alexey. Sweat gland story is interesting. Stem cells for heart disease is a key, exciting area, but still early days….still definitely one to watch! I have trouble …

TGIF: stem cell headlines according to Google & my take on them Read More »